Clinical trial
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
NCT00287521 · Alcon Research, Industry · Completed
Key facts
| NCT number | NCT00287521 |
|---|---|
| Title | A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension |
| Lead sponsor | Alcon Research, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Open-angle Glaucoma, Ocular Hypertension |
| Intervention type | Drug, Other |
| Interventions | AL-37807 Ophthalmic Suspension, 1.0%, Latanoprost, 0.005% (Xalatan), AL-37807 Vehicle, Timolol Maleate Ophthalmic Gel Forming Solution, 0.5% |
| Enrollment | 87 |
| Start date | Nov 1, 2005 |
| Primary completion | Feb 1, 2006 |
| Completion | Feb 1, 2006 |
| First posted | Feb 7, 2006 |
| Last update posted | Mar 5, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: